awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39895097-05068042-4C1F-483E-B7EE-048E519AFF1F
Q39895097-05068042-4C1F-483E-B7EE-048E519AFF1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39895097-05068042-4C1F-483E-B7EE-048E519AFF1F
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.
P2860
Q39895097-05068042-4C1F-483E-B7EE-048E519AFF1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39895097-05068042-4C1F-483E-B7EE-048E519AFF1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
837577d79130dec7dca7f467a38d6f3d9b013c57
P2860
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.